← 返回

动态肿瘤免疫芯片用于外周血来源的肿瘤反应性 T 细胞扩增

英文原题:Dynamic Tumor Immunology-on-a-Chip for Peripheral Blood-Derived Tumor-Reactive T Cell Expansion.

查看英文原题

Dynamic Tumor Immunology-on-a-Chip for Peripheral Blood-Derived Tumor-Reactive T Cell Expansion.

PubMed 2025/03/21(内容时间) Research (Wash D C) Q1 · IF 12.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

过继性T细胞疗法在实体瘤治疗中展现出巨大前景,然而以经济有效的方式获取自体肿瘤反应性T细胞面临巨大挑战。在此,我们提出了一种动态肿瘤免疫芯片,模拟免疫反应,用于实现肿瘤反应性T细胞的富集与扩增。通过将肿瘤细胞接种于水凝胶包埋的微柱阵列中,可生成尺寸均一的肿瘤球体,并在去除水凝胶后将其捕获。随后,在鱼骨图案微沟槽阵列提供的仿生流动条件下,灌注T细胞并与这些肿瘤球体充分接触。我们发现,驯化的肿瘤反应性T细胞可被完全激活,并在培养过程中实现快速克隆增殖。此外,这些肿瘤反应性T细胞在体外表现出特异且强大的杀瘤能力。因此,所提出的具有分阶段结构可转化特性的动态微流控芯片,既实现了肿瘤球体的可重复制备,又重现了肿瘤-免疫交互作用以扩增肿瘤反应性T细胞。这些特征表明,该动态且可重复的肿瘤免疫芯片在制备用于临床癌症免疫治疗的治疗性T细胞产品方面具有潜力。

展开英文摘要原文

Adoptive T cell therapy has shown great promise in the treatment of solid tumors, which, however, poses a great challenge to obtain autologous tumor-reactive T cells in a cost-effective manner.

Here, we present a dynamic tumor immunology-on-a-chip, mimicking immune responses, for achieving the enrichment and expansion of tumor-reactive T cells. Tumor spheroids with uniform size can be generated by seeding tumor cells in hydrogel-embedded micropillar arrays, and could be trapped upon removal of hydrogel. Then, T cells were infused and fully contacted with these tumor spheroids under biomimetic flow conditions provided by herringbone-patterned microgrooves arrays.

We found that the tamed tumor-reactive T cells could be fully activated and a rapid clonal proliferation was realized during the cultivation.

In addition, these tumor-reactive T cells exhibited a specific and powerful tumor-killing capability in vitro.

Thus, the suggested dynamic microfluidic chips with staged structure-transformable properties realize both the producible formation of tumor spheroids and the recapitulation of tumor-immune crosstalk to expand tumor-reactive T cells. These features indicate that the dynamic and reproducible tumor immunology-on-a-chip has potential in the preparation of therapeutic T cell products for clinical cancer immunotherapy.

论文信息

作者
Shou X、Yu Y、Wu D、Lu P、Zhao M、Zhao Y
单位
Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.China
期刊
Research (Washington, D.C.)2025
原文标识
PubMed 40123996 · DOI 10.34133/research.0639